Cadrenal Therapeutics, Inc. Common Stock
Stock Forecast, Prediction & Price Target
Cadrenal Therapeutics, Inc. Common Stock (CVKD) stock Price Target by analysts
$32
Potential upside: 128.73%
Cadrenal Therapeutics, Inc. Common Stock price prediction
What is Cadrenal Therapeutics, Inc. Common Stock stock analysts` prediction?
Cadrenal Therapeutics, Inc. Common Stock stock forecast: Based on 1 Wall Street analysts` predicted price targets for Cadrenal Therapeutics, Inc. Common Stock in the last 3 months, the avarage price target is $32, with a high forecast of $NaN. The average price target represents a 128.73% change from the last price of $13.99.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Cadrenal Therapeutics, Inc. Common Stock stock Price Target by analysts
Full breakdown of analysts given Cadrenal Therapeutics, Inc. Common Stock price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Joseph Pantginis H.C. Wainwright | 0% 0/1 | 11 months ago | $32 128.73% upside | $14.93 | StreetInsider | Previous targets (0) |
Cadrenal Therapeutics, Inc. Common Stock Financial Estimates
Cadrenal Therapeutics, Inc. Common Stock Revenue Estimates
Cadrenal Therapeutics, Inc. Common Stock EBITDA Estimates
Cadrenal Therapeutics, Inc. Common Stock Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 | |
Revenue
% change YoY
| $0 N/A | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $6.3M Low: $6.3M High: $6.3M avg. 0% | Avg: $16.8M Low: $16.8M High: $16.8M avg. 166.66% | |
Net Income
% change YoY
| $-6.71M N/A | $-8.35M -24.46% | Avg: $-10.06M Low: $-5.99M High: $-2.86M avg. -20.37% | Avg: $-12.43M Low: $-6.25M High: $-2.73M avg. -23.58% | Avg: $-5.46M Low: $-5.46M High: $-5.46M avg. 56.00% | Avg: $-2.99M Low: $-2.99M High: $-2.99M avg. 45.23% | |
EBITDA
% change YoY
| $-2.70M N/A | $-8.33M -208.77% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
EPS
% change YoY
| -$0.58 N/A | -$9.63 -1560.34% | Avg: -$0.34 Low: -$0.46 High: -$0.22 avg. 96.46% | Avg: -$0.35 Low: -$0.48 High: -$0.21 avg. -1.47% | Avg: -$0.42 Low: -$0.42 High: -$0.42 avg. -21.73% | Avg: -$0.23 Low: -$0.23 High: -$0.23 avg. 45.23% | |
Operating Expenses
% change YoY
| $2.70M N/A | $7.63M 182.65% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
FAQ
What is Cadrenal Therapeutics, Inc. Common Stock stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 14.32% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -5.99M, average is -10.06M and high is -2.86M.
What is Cadrenal Therapeutics, Inc. Common Stock stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 41.66% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Cadrenal Therapeutics, Inc. Common Stock stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 29.62% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.46, average is -$0.34 and high is $-0.22.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Cadrenal Therapeutics, Inc. Common Stock stock. The most successful analyst is Joseph Pantginis.